CVS Health Corporation (TSX:CVS)
Canada · Delayed Price · Currency is CAD 20.55
-0.20 (-0.96%)
Oct 6, 2026, 3:47 PM EST
CVS Health Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 157,191 | 138,130 | 81,280 | 134,194 | 165,724 | 172,454 | |
Market Cap Growth | 14.65% | 69.94% | -39.43% | -19.03% | -3.90% | 51.39% |
Enterprise Value | 246,131 | 235,071 | 186,583 | 218,821 | 235,305 | 256,137 |
Last Close Price | 20.55 | 18.89 | 10.46 | 18.09 | 21.68 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.64 | 56.98 | 12.24 | 12.18 | 28.40 | 17.03 |
PS Ratio | 0.27 | 0.25 | 0.15 | 0.28 | 0.38 | 0.47 |
PB Ratio | 1.39 | 1.34 | 0.75 | 1.33 | 1.71 | 1.81 |
P/FCF Ratio | 9.41 | 12.90 | 8.93 | 9.78 | 9.10 | 8.65 |
P/OCF Ratio | 7.49 | 9.47 | 6.20 | 7.57 | 7.57 | 7.46 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.42 | 0.43 | 0.35 | 0.47 | 0.54 | 0.70 |
EV/EBITDA Ratio | 8.79 | 11.72 | 10.28 | 8.99 | 8.71 | 10.86 |
EV/EBIT Ratio | 14.24 | 17.11 | 16.17 | 11.77 | 11.04 | 14.30 |
EV/FCF Ratio | 14.74 | 21.96 | 20.50 | 15.94 | 12.93 | 12.86 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.96 | 1.06 | 1.10 | 1.04 | 0.99 | 1.01 |
Debt / EBITDA Ratio | 3.87 | 4.53 | 5.30 | 3.68 | 3.06 | 3.48 |
Debt / FCF Ratio | 6.49 | 10.24 | 13.11 | 7.64 | 5.26 | 4.83 |
Net Debt / Equity Ratio | 0.78 | 0.92 | 0.95 | 0.89 | 0.77 | 0.84 |
Net Debt / EBITDA Ratio | 3.74 | 4.74 | 5.70 | 3.68 | 2.76 | 3.41 |
Net Debt / FCF Ratio | 5.30 | 8.88 | 11.37 | 6.54 | 4.09 | 4.03 |
Asset Turnover | 1.61 | 1.58 | 1.47 | 1.49 | 1.40 | 1.25 |
Inventory Turnover | 20.32 | 18.56 | 17.79 | 16.35 | 14.54 | 13.24 |
Quick Ratio | 0.62 | 0.57 | 0.56 | 0.59 | 0.62 | 0.55 |
Current Ratio | 0.87 | 0.84 | 0.81 | 0.86 | 0.95 | 0.89 |
Return on Equity (ROE) | 6.21% | 2.29% | 6.02% | 11.28% | 5.88% | 11.01% |
Return on Assets (ROA) | 2.97% | 2.47% | 1.99% | 3.68% | 4.27% | 3.82% |
Return on Invested Capital (ROIC) | 7.17% | 5.54% | 4.09% | 7.77% | 8.79% | 7.59% |
Return on Capital Employed (ROCE) | 7.30% | 6.10% | 4.80% | 8.30% | 9.90% | 8.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.42% | 1.75% | 8.17% | 8.21% | 3.52% | 5.87% |
FCF Yield | 10.62% | 7.75% | 11.20% | 10.23% | 10.98% | 11.55% |
Dividend Yield | 3.07% | 19.31% | 36.58% | 17.67% | 13.73% | - |
Payout Ratio | 69.86% | 192.14% | 73.10% | 37.54% | 67.43% | 32.81% |
Buyback Yield / Dilution | -1.19% | -0.71% | 2.17% | 2.49% | 0.45% | -1.14% |
Total Shareholder Return | 1.89% | 18.60% | 38.75% | 20.16% | 14.18% | -1.14% |